{
  "report_rows": [
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$3.51 vs. cons $3.46",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted net revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$3.14B vs. cons $3.16B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Normalized constant-currency adjusted net revenue growth",
      "prediction": "MISS",
      "answer": "pred ~3.7% vs. cons 4.0%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Adjusted EPS",
      "prediction": "BETTER",
      "answer": "guide ~$13.90 midpoint vs. cons $13.82 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Normalized constant-currency adjusted net revenue growth",
      "prediction": "LOWER",
      "answer": "guide ~4.5% vs. cons 5.0% (FY2026)",
      "confidence": "LOW"
    },
    {
      "kpi": "Normalized adjusted operating-margin expansion",
      "prediction": "UNCHANGED",
      "answer": "guide ~150 bps vs. cons 150 bps (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Normalized constant-currency adjusted net revenue growth",
      "prediction": "LOWER",
      "answer": "guide ~4.8% vs. cons 5.3% (2H2026)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -4.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -6.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "A Q2 organic-growth result of ~3.7% vs. 4.0% consensus and a 2H2026 outlook of ~4.8% vs. 5.3% consensus would outweigh an EPS beat; weaker out-period revenue assumptions should pull FY2027 estimates lower after day 1.",
  "day5_confidence": "MEDIUM"
}